Industry: Chemical & Material
Published Date: 2025-02-21
Pages: 90 Pages
Report ld: 4157647
Request Sample
Customized Report
The global market for Ertapenem Sodium was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Ertapenem is a carbapenems antibiotic with strong antibacterial activity and broad antibacterial spectrum. CAS number is 153773-82-1.
North American market for Ertapenem Sodium is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Ertapenem Sodium is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Ertapenem Sodium include Tecoland, Qilu Pharmaceutical, Gland Pharma, Sun Pharma, Zhejiang New Donghai Pharmaceutical, Savior Lifetec Corporation, Aurobindo, CSPC, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
MARKET SEGMENTATION
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Ertapenem Sodium, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ertapenem Sodium.
The Ertapenem Sodium market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Ertapenem Sodium market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ertapenem Sodium manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Ertapenem Sodium manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Ertapenem Sodium by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Ertapenem Sodium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Ertapenem Sodium Market Overview
1.1 Product Definition
1.2 Ertapenem Sodium by Type
1.2.1 Global Ertapenem Sodium Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Purity≥98%
1.2.3 Purity≥99%
1.3 Ertapenem Sodium by Application
1.3.1 Global Ertapenem Sodium Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Ertapenem Sodium Injection
1.3.3 Other
1.4 Global Market Growth Prospects
1.4.1 Global Ertapenem Sodium Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Ertapenem Sodium Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Ertapenem Sodium Production Estimates and Forecasts (2020-2031)
1.4.4 Global Ertapenem Sodium Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Ertapenem Sodium Production Market Share by Manufacturers (2020-2025)
2.2 Global Ertapenem Sodium Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Ertapenem Sodium, Industry Ranking, 2023 VS 2024
2.4 Global Ertapenem Sodium Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Ertapenem Sodium Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Ertapenem Sodium, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Ertapenem Sodium, Product Offered and Application
2.8 Global Key Manufacturers of Ertapenem Sodium, Date of Enter into This Industry
2.9 Ertapenem Sodium Market Competitive Situation and Trends
2.9.1 Ertapenem Sodium Market Concentration Rate
2.9.2 Global 5 and 10 Largest Ertapenem Sodium Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Ertapenem Sodium Production by Region
3.1 Global Ertapenem Sodium Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Ertapenem Sodium Production Value by Region (2020-2031)
3.2.1 Global Ertapenem Sodium Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Ertapenem Sodium by Region (2026-2031)
3.3 Global Ertapenem Sodium Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Ertapenem Sodium Production Volume by Region (2020-2031)
3.4.1 Global Ertapenem Sodium Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Ertapenem Sodium by Region (2026-2031)
3.5 Global Ertapenem Sodium Market Price Analysis by Region (2020-2025)
3.6 Global Ertapenem Sodium Production and Value, Year-over-Year Growth
3.6.1 North America Ertapenem Sodium Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Ertapenem Sodium Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Ertapenem Sodium Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Ertapenem Sodium Production Value Estimates and Forecasts (2020-2031)
4 Ertapenem Sodium Consumption by Region
4.1 Global Ertapenem Sodium Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Ertapenem Sodium Consumption by Region (2020-2031)
4.2.1 Global Ertapenem Sodium Consumption by Region (2020-2025)
4.2.2 Global Ertapenem Sodium Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Ertapenem Sodium Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Ertapenem Sodium Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Ertapenem Sodium Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Ertapenem Sodium Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Ertapenem Sodium Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Ertapenem Sodium Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Ertapenem Sodium Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Ertapenem Sodium Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Ertapenem Sodium Production by Type (2020-2031)
5.1.1 Global Ertapenem Sodium Production by Type (2020-2025)
5.1.2 Global Ertapenem Sodium Production by Type (2026-2031)
5.1.3 Global Ertapenem Sodium Production Market Share by Type (2020-2031)
5.2 Global Ertapenem Sodium Production Value by Type (2020-2031)
5.2.1 Global Ertapenem Sodium Production Value by Type (2020-2025)
5.2.2 Global Ertapenem Sodium Production Value by Type (2026-2031)
5.2.3 Global Ertapenem Sodium Production Value Market Share by Type (2020-2031)
5.3 Global Ertapenem Sodium Price by Type (2020-2031)
6 Segment by Application
6.1 Global Ertapenem Sodium Production by Application (2020-2031)
6.1.1 Global Ertapenem Sodium Production by Application (2020-2025)
6.1.2 Global Ertapenem Sodium Production by Application (2026-2031)
6.1.3 Global Ertapenem Sodium Production Market Share by Application (2020-2031)
6.2 Global Ertapenem Sodium Production Value by Application (2020-2031)
6.2.1 Global Ertapenem Sodium Production Value by Application (2020-2025)
6.2.2 Global Ertapenem Sodium Production Value by Application (2026-2031)
6.2.3 Global Ertapenem Sodium Production Value Market Share by Application (2020-2031)
6.3 Global Ertapenem Sodium Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Tecoland
7.1.1 Tecoland Ertapenem Sodium Company Information
7.1.2 Tecoland Ertapenem Sodium Product Portfolio
7.1.3 Tecoland Ertapenem Sodium Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Tecoland Main Business and Markets Served
7.1.5 Tecoland Recent Developments/Updates
7.2 Qilu Pharmaceutical
7.2.1 Qilu Pharmaceutical Ertapenem Sodium Company Information
7.2.2 Qilu Pharmaceutical Ertapenem Sodium Product Portfolio
7.2.3 Qilu Pharmaceutical Ertapenem Sodium Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Qilu Pharmaceutical Main Business and Markets Served
7.2.5 Qilu Pharmaceutical Recent Developments/Updates
7.3 Gland Pharma
7.3.1 Gland Pharma Ertapenem Sodium Company Information
7.3.2 Gland Pharma Ertapenem Sodium Product Portfolio
7.3.3 Gland Pharma Ertapenem Sodium Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Gland Pharma Main Business and Markets Served
7.3.5 Gland Pharma Recent Developments/Updates
7.4 Sun Pharma
7.4.1 Sun Pharma Ertapenem Sodium Company Information
7.4.2 Sun Pharma Ertapenem Sodium Product Portfolio
7.4.3 Sun Pharma Ertapenem Sodium Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Sun Pharma Main Business and Markets Served
7.4.5 Sun Pharma Recent Developments/Updates
7.5 Zhejiang New Donghai Pharmaceutical
7.5.1 Zhejiang New Donghai Pharmaceutical Ertapenem Sodium Company Information
7.5.2 Zhejiang New Donghai Pharmaceutical Ertapenem Sodium Product Portfolio
7.5.3 Zhejiang New Donghai Pharmaceutical Ertapenem Sodium Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Zhejiang New Donghai Pharmaceutical Main Business and Markets Served
7.5.5 Zhejiang New Donghai Pharmaceutical Recent Developments/Updates
7.6 Savior Lifetec Corporation
7.6.1 Savior Lifetec Corporation Ertapenem Sodium Company Information
7.6.2 Savior Lifetec Corporation Ertapenem Sodium Product Portfolio
7.6.3 Savior Lifetec Corporation Ertapenem Sodium Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Savior Lifetec Corporation Main Business and Markets Served
7.6.5 Savior Lifetec Corporation Recent Developments/Updates
7.7 Aurobindo
7.7.1 Aurobindo Ertapenem Sodium Company Information
7.7.2 Aurobindo Ertapenem Sodium Product Portfolio
7.7.3 Aurobindo Ertapenem Sodium Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Aurobindo Main Business and Markets Served
7.7.5 Aurobindo Recent Developments/Updates
7.8 CSPC
7.8.1 CSPC Ertapenem Sodium Company Information
7.8.2 CSPC Ertapenem Sodium Product Portfolio
7.8.3 CSPC Ertapenem Sodium Production, Value, Price and Gross Margin (2020-2025)
7.8.4 CSPC Main Business and Markets Served
7.8.5 CSPC Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Ertapenem Sodium Industry Chain Analysis
8.2 Ertapenem Sodium Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Ertapenem Sodium Production Mode & Process Analysis
8.4 Ertapenem Sodium Sales and Marketing
8.4.1 Ertapenem Sodium Sales Channels
8.4.2 Ertapenem Sodium Distributors
8.5 Ertapenem Sodium Customer Analysis
9 Ertapenem Sodium Market Dynamics
9.1 Ertapenem Sodium Industry Trends
9.2 Ertapenem Sodium Market Drivers
9.3 Ertapenem Sodium Market Challenges
9.4 Ertapenem Sodium Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Ertapenem Sodium market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-09
Pages: 133
USD 4900.00
(Single User License)
The global Ertapenem Sodium market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 79
USD 4250.00
(Single User License)
The global market for Ertapenem Sodium was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-03-05
Pages: 103
USD 3950.00
(Single User License)
The global Ertapenem Sodium market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-03-05
Pages: 134
USD 2900.00
(Single User License)
The global Ertapenem Sodium market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-25
Pages: 143
USD 4900.00
(Single User License)
The global Ertapenem Sodium market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 77
USD 4250.00
(Single User License)
The global market for Ertapenem Sodium was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 105
USD 3950.00
(Single User License)
Ertapenem is a carbapenems antibiotic with strong antibacterial activity and broad antibacterial spectrum. CAS number is 153773-82-1.
Published Date: 2024-06-17
Pages: 116
USD 4350.00
(Single User License)
Ertapenem is a carbapenems antibiotic with strong antibacterial activity and broad antibacterial spectrum. CAS number is 153773-82-1.
Published Date: 2024-06-17
Pages: 95
USD 3950.00
(Single User License)
Ertapenem is a carbapenems antibiotic with strong antibacterial activity and broad antibacterial spectrum. CAS number is 153773-82-1.
Published Date: 2024-06-17
Pages: 148
USD 4900.00
(Single User License)
The global Ertapenem Sodium market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-09
Pages: 133
The global Ertapenem Sodium market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 79
The global market for Ertapenem Sodium was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-03-05
Pages: 103
The global Ertapenem Sodium market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-03-05
Pages: 134
The global Ertapenem Sodium market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-25
Pages: 143
The global Ertapenem Sodium market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 77
The global market for Ertapenem Sodium was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 105
Ertapenem is a carbapenems antibiotic with strong antibacterial activity and broad antibacterial spectrum. CAS number is 153773-82-1.
Published: 2024-06-17
Pages: 116
Ertapenem is a carbapenems antibiotic with strong antibacterial activity and broad antibacterial spectrum. CAS number is 153773-82-1.
Published: 2024-06-17
Pages: 95
Ertapenem is a carbapenems antibiotic with strong antibacterial activity and broad antibacterial spectrum. CAS number is 153773-82-1.
Published: 2024-06-17
Pages: 148
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now